enVVeno Medical Corporation NVNO
8.67
(0.42)
(4.62%)
as of 25 Sep
- Market cap
- $6.3M
- P/E
- 0.0×
Follow NVNO
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
— | — | — | — |
+8 more quarters Free account |
EV/Sales |
— | — | — | — | |
EV/FCF |
— | — | — | — | |
Quick Ratio |
11.39 | 11.63 | 13.30 | 12.90 | |
Current Ratio |
11.70 | 11.89 | 13.58 | 13.12 | |
Net Debt/EBITDA |
5.70 | 6.33 | 7.24 | 6.50 | |
Debt/Assets |
0.00% | 0.00% | 0.00% | 0.00% | |
Debt/Equity |
0.00 | 0.00 | 0.00 | 0.00 | |
Asset Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.99 | 0.84 | 0.92 | 0.97 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Free Cash Flow Yield |
— | — | — | — | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(5.29) | (4.95) | (5.85) | (7.65) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(5.29) | (4.95) | (5.85) | (7.65) | |
Cash per Share |
32.02 | 38.12 | 47.90 | 53.89 | |
Shareholders Equity per Share |
30.80 | 36.31 | 46.06 | 51.27 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
30.80 | 36.31 | 46.06 | 51.27 | |
Free Cash Flow |
(3.55) | (3.24) | (3.44) | (4.39) | |
Working Capital |
20.20 | 23.35 | 26.70 | 29.10 | |
Capital Expenditures |
— | — | 0.00 | 0.00 | |
Net Current Asset Value |
20.09 | 23.14 | 26.39 | 28.59 | |
EV/EBIT |
— | — | — | — | |
Capex to Sales |
— | — | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | |
| Other line items | |||||
Average Payables |
2.06 | 1.52 | 1.73 | 1.99 | |
Average Assets |
29.62 | 33.34 | 37.26 | 41.37 | |
Average Common Equity |
26.86 | 31.03 | 34.64 | 38.41 |
Columns are period end dates